GondolaBio
Develops clinical-stage therapeutics for rare genetic diseases.
biotechpharmaceuticals
Company facts
- Founded
- 2024
- Employees
- 45
- Headquarters
- United States
- Type
- Private
- Funding
- Corporate Round · $300M · 2024
- Subsidiaries
- Portal Therapeutics
Open positions
2 jobs
15 views last week
Associate Director/Director/Sr. Director, Business Development & Operations
New North AmericaSenior
United States
Palo Alto, CA, San Francisco, CA, Boston, MAAbout GondolaBio GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. A sister company of BridgeBio, GondolaBio secured $300M in private…